A Phase I, Single Blind, Randomized, Placebo Controlled, Drug Interaction Study of Intravenous (IV) Valortim and Intravenous (IV) Doxycycline in Healthy Normal Subjects

Trial Profile

A Phase I, Single Blind, Randomized, Placebo Controlled, Drug Interaction Study of Intravenous (IV) Valortim and Intravenous (IV) Doxycycline in Healthy Normal Subjects

Discontinued
Phase of Trial: Phase I

Latest Information Update: 01 Feb 2016

At a glance

  • Drugs MDX 1303 (Primary) ; Doxycycline
  • Indications Anthrax
  • Focus Adverse reactions
  • Sponsors PharmAthene
  • Most Recent Events

    • 09 Aug 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 05 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top